Orgenesis Inc.

POCare - Therapies

SHARE

Our POCare Platform overcomes conventional processing challenges by enabling sterile, scalable onsite processing for a pipeline of advanced therapies

Most popular related searches
  • Most research and biotechnology entities are good at science but need help with their development strategy and the scale up process to treat patients.
  • We identify promising therapies and bring their development into our POCare Platform to overcome these challenges.
  • The result: a pipeline of advanced therapies that are expertly and efficiently brought to market for point of care production and use.
  • Our POCare Platform seeks to accelerate the development of life-changing therapies to potentially reduce costs to the healthcare system.
  • Partners benefit from Orgenesis’ extensive know-how in CGT process development and validation, and we benefit from long-term economic opportunities through processing licenses and royalties at the POCare Network level.
  • Immuno-Oncology
  • Viral Diseases
  • Metabolic & Autoimmune Diseases
  • Vascular & Musculoskeletal Diseases
  • Kidney Disease